■■ Adherence and Persistence Among Chronic Myeloid Leukemia Patients During Second-Line Tyrosine Kinase Inhibitor Treatment

DISCLOSURES: Chen is an employee of Novartis Pharmaceuticals Corporation. Wu is an employee of Analysis Group, Inc., which has received funding from Novartis Pharmaceuticals Corporation.